OTR Acquisition (OTRAU) Stock Price, News & Analysis

Company Overview

OTR Acquisition Corp. is a blank‐check special purpose acquisition company incorporated in Delaware and trading on the OTC Markets under the symbol OTRAU. As a SPAC, it was formed with the sole purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Prior to completing a business combination, OTR Acquisition Corp. does not conduct any operations or generate revenue. The company raises capital through its initial public offering and holds proceeds in a trust account, with the objective of identifying attractive acquisition targets in North America across a broad range of industries.

OTR Acquisition Corp.’s management and sponsor team comprises professionals with backgrounds in corporate finance, mergers and acquisitions, and strategic development. Until the completion of its initial business combination, the company’s activities are focused on sourcing potential targets, performing due diligence, and fulfilling the regulatory requirements applicable to SPACs.

Key Stats

• Today's Range: $9.55 to $9.56
• 50-Day Range: $9.55 to $9.55
• 52-Week Range: $9.20 to $14.23
• Volume: 200 shs
• Average Volume: 4,515 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OTRAU Stock Analysis - Frequently Asked Questions

How have OTRAU shares performed this year?

OTR Acquisition's stock was trading at $9.55 on January 1st, 2025. Since then, OTRAU stock has increased by 0.0% and is now trading at $9.55.

How do I buy shares of OTR Acquisition?

Shares of OTRAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Manufacturing
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:OTRAU
• CIK: 1821318
• Web: otracquisition.com
• Phone: 305 697 9600
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A